Signals
-
Health
No New Safety Signals Seen With Migraine Prevention Drug
Meeting Coverage > AAN — At 48 weeks, atogepant showed consistent safety profile and efficacy by Judy George, Deputy Managing…
Read More »
Meeting Coverage > AAN — At 48 weeks, atogepant showed consistent safety profile and efficacy by Judy George, Deputy Managing…
Read More »